Allosterism of Nicotinic Acetylcholine Receptors: Therapeutic Potential for Neuroinflammation Underlying Brain Trauma and Degenerative Disorders
| Autor: | Shailesh Khatri, Abel Bult-Ito, Swarup Mitra, Malabika Maulik, Marvin K. Schulte |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Multiple Sclerosis
Allosteric regulation Cholinergic Agents Inflammation Nerve Tissue Proteins Review Receptors Nicotinic Catalysis neuroinflammation lcsh:Chemistry Inorganic Chemistry Therapeutic approach Allosteric Regulation Alzheimer Disease Brain Injuries Traumatic medicine Humans Physical and Theoretical Chemistry lcsh:QH301-705.5 Molecular Biology Spectroscopy Neuroinflammation Acetylcholine receptor business.industry Organic Chemistry Neurodegenerative Diseases Parkinson Disease General Medicine Computer Science Applications Nicotinic agonist lcsh:Biology (General) lcsh:QD1-999 Drug development Cholinergic nicotinic acetylcholine receptors allosteric modulators medicine.symptom Inflammation Mediators business Neuroscience |
| Zdroj: | International Journal of Molecular Sciences International Journal of Molecular Sciences, Vol 21, Iss 4918, p 4918 (2020) |
| ISSN: | 1422-0067 |
| Popis: | Inflammation is a key physiological phenomenon that can be pervasive when dysregulated. Persistent chronic inflammation precedes several pathophysiological conditions forming one of the critical cellular homeostatic checkpoints. With a steady global surge in inflammatory diseases, it is imperative to delineate underlying mechanisms and design suitable drug molecules targeting the cellular partners that mediate and regulate inflammation. Nicotinic acetylcholine receptors have a confirmed role in influencing inflammatory pathways and have been a subject of scientific scrutiny underlying drug development in recent years. Drugs designed to target allosteric sites on the nicotinic acetylcholine receptors present a unique opportunity to unravel the role of the cholinergic system in regulating and restoring inflammatory homeostasis. Such a therapeutic approach holds promise in treating several inflammatory conditions and diseases with inflammation as an underlying pathology. Here, we briefly describe the potential of cholinergic allosterism and some allosteric modulators as a promising therapeutic option for the treatment of neuroinflammation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |